Signal active
Organization
Contact Information
Overview
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies. Its platform cultures the most realistic human tissues ever lab-grown to answer deep questions about human health.
About
Biotechnology, Lifestyle, Medical
2020
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Vivodyne headquartered in United States, North America, operates in the Biotechnology, Lifestyle, Medical sector. The company focuses on Biotechnology and has secured $960.0M in funding across 24 round(s). With a team of 11-50 employees, Vivodyne is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Vivodyne, raised $38.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
2
5
0
$40.0M
Details
2
Vivodyne has raised a total of $40.0M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | 2.0M | ||
2023 | Seed | 38.0M |
Investors
Vivodyne is funded by 11 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
CS Venture Opportunities Fund | - | FUNDING ROUND - CS Venture Opportunities Fund | 38.0M |
Alex Andrianopoulos | - | FUNDING ROUND - Alex Andrianopoulos | 38.0M |
Vivodyne | - | FUNDING ROUND - Vivodyne | 38.0M |
Kairos Ventures | - | FUNDING ROUND - Kairos Ventures | 38.0M |
Recent Activity
There is no recent news or activity for this profile.